Ramsay Générale de Santé SA reported interim results for the nine-month period ending March 31, 2025, with group revenue reaching €3.889 billion, marking a 5.1% increase compared to the previous year. This growth was supported by activity volume growth and the acquisition of Cosem primary care centers in June 2024. On a like-for-like basis, revenue grew by 3.2%. The group's EBITDA was nearly stable at €441 million, showing a slight decrease of 0.8% or €3.6 million compared to the same period last year. This stability absorbed the impact of the French government's withholding of the prudential coefficient, reduced subsidies, increased salaries, and procurement inflation. Net cash flow from operating activities decreased by €50 million to €282 million, largely due to the repayment of French government cash advances and working capital timing differences. Reported net financial debt stood at €3.859 billion as of March 31, 2025, with a restated net leverage of 5.7x. CEO Pascal Roché highlighted that the group's EBITDA was affected by a €25 million reduction in the French government's revenue guarantee, a €14.7 million price decrease due to withholding of the prudential coefficient, and the absence of a €17 million inflation grant received in the previous year. The group continues to focus on cash flow generation through operational efficiency and working capital improvement. Additionally, Ramsay Santé is expanding day hospitals in France to align with patients' healthcare needs, aiming for future profitable growth.